Korean J Gynecol Oncol.  2005 Jun;16(2):113-122.

Immunohistochemical study of 14-3-3-sigma and -zeta in ovarian cancer

• Park JK
• Shin JK
• Choi WJ
• Lee SA
• Lee JH
• Paik WY

Abstract

OBJECTIVE
To evaluate the expression level, localization and distribution of 14-3-3sigma and zeta proteins in human ovarian epithelial carcinoma cells.
METHODS
Epithelial carcinoma, benign epithelial tumor and normal ovarian tissues were evaluated by immunohistochemistry. For this study, mucinous adenoma (n=10), serous adenoma (n=10), mucinous adenocarcinoma (n=10) and serous adenocarcinoma (n=10) of ovary and normal ovarian tissue (n=10) were analyzed. Goat anti 14-3-3sigma polyclonal antibody and rabbit anti-14-3-3zeta polyclonal antibody were used as primary antibodies.
RESULTS
The 14-3-3sigma protein expression in the glandular epithelium was not statistically different among normal ovary, cystadenoma and cystadenocarcinoma. The 14-3-3zeta protein expression in the glandular epithelium was significantly higher for cystadenocarcinoma than for cystadenoma and normal ovary. The 14-3-3sigma and zeta proteins were immunohistochemically demonstrated in the nuclei and more preferably in the cytoplasm of adenocarcinoma epithelial cells.
CONCLUSION
The expression of 14-3-3zeta protein increased significantly in ovarian adenocarcinoma compared with adenoma and normal ovary. It is suggested that 14-3-3zeta protein expression may play an important role in abnormal growth of ovarian epithelial tumor cell.

Keyword

14-3-3sigma; 14-3-3zeta; Ovarian epithelial carcinoma; Immunohistochemistry

MeSH Terms

14-3-3 Proteins
Adenocarcinoma
Adenocarcinoma, Mucinous
Adenoma
Antibodies
Cystadenocarcinoma
Cystadenoma
Cytoplasm
Epithelial Cells
Epithelium
Female
Goats
Humans
Immunohistochemistry
Mucins
Ovarian Neoplasms*
Ovary
14-3-3 Proteins
Antibodies
Mucins